Integrated Development and Production of Diagnostic Reagents by the Biodiagnostic Reagent Center
First written in FY2018. 1 of 4 entries say "Advanced", first in FY2019-Q1. Latest entry: FY2020.
No other company in this theme has enough history to compare yet.
- FY2020AchievedAnnual report
「To improve the competitiveness of biodiagnostic products and ensure a stable supply, we opened the biodiagnostics facility Technopark East Site at Technopark, our core R&D facility in Nishi Ward, Kobe, and began operations in April 2019.」
The Biodiagnostics Center progressed from the construction and planned-operation stage to the opening of Technopark East Site and the start of operations in April 2019. - FY2019-Q2RestatedAnnual report
「We are constructing a Biodiagnostics Center at the Seishin Industrial Park in Nishi Ward, Kobe, adjacent to Technopark, our core R&D facility. To strengthen our businesses in blood coagulation testing, immunoassay testing and life sciences, the center will integrate the R&D, raw material procurement, production and logistics of diagnostic reagents that use advanced biotechnology, including proteins, with the aim of improving product competitiveness and ensuring a stable supply of biodiagnostic reagents. The center is scheduled to begin operations in April 2019.」
The construction of the Biodiagnostics Center, its integrated R&D, raw material procurement, production and logistics framework, and the planned start of operations in April 2019 have been reiterated. - FY2019-Q1AdvancedAnnual report
「We are constructing a Biodiagnostics Center at the Seishin Industrial Park in Nishi Ward, Kobe, adjacent to Technopark, our core R&D facility. To strengthen our businesses in blood coagulation testing, immunoassay testing and life sciences, the center will integrate the R&D, raw material procurement, production and logistics of diagnostic reagents that use advanced biotechnology, including proteins, with the aim of improving product competitiveness and ensuring a stable supply of biodiagnostic reagents. The center is scheduled to begin operations in April 2019.」
Construction of the Biodiagnostics Center is continuing, with the integrated R&D, raw material procurement, production and logistics framework scheduled to begin operations in April 2019. - FY2018First statedAnnual report
「To improve the competitiveness of specimen testing reagents and ensure a stable supply, we proceeded with the establishment in Japan of a Biodiagnostics Center integrating raw material procurement, development and production,」
The establishment of a Biodiagnostics Center integrating raw material procurement, development and production is under way. The facility plan calls for planned investment of ¥18,000 million, ¥4,824 million already paid, construction commencing in October 2017 and completion in February 2019.